MedTrace Logo

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV

NCT07032103 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-06-22

No results posted yet for this study

Summary

This prospective study enrolls patients who are diagnosed with aggressive lymphoma including Hodgkin and non-Hodgkin lymphomas. Enrolled patients will be treated according to our institution' treatment policy in clinical practice. The disease status including response to therapy and survival status will be regularly updated during the study period. Patients' serum and cell-free DNA will be collected and analyzed.

Conditions

Interventions

DRUG

Immunochemotherapy

Systemic chemotherapy with curative intent

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2028-12-30
Completion
2028-12-30
FDA Drug
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07032103 on ClinicalTrials.gov